Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Patent granted for mammary aspirate specimen cytology test
April 6th, 2004
Nastech Pharmaceutical Co., Inc., (NSTK) announced the issuance of a second U.S. patent, no. 6,689,073, entitled "Methods and Devices for Collecting, Handling and Processing Mammary Fluid Samples for Evaluating Breast Diseases, Including Cancer." The patent contains 48 claims relating to methods, devices, and kits for obtaining and assaying biological samples from mammary fluid and cytological samples from the mammary glands of a mammalian subject for evaluating, diagnosing, and managing breast disease, including infections, precancerous conditions, cancer susceptibility, and cancer. This is the second issued patent relating to the Mammary Aspirate...
Source: Cancer Weekly (2004-04-06)
|
